Congress of psychiatry

Symposium (German)
10:00 – 11:30
 | 
Room M8
TOPIC 44:
 Other topics
 
Forschung in der psychiatrischen Pflege – yes, 
we can???
›
 DGPPN Section: Psychiatrische Pflege
Chairs: 
Reinhard Bachmann, Austria 
Ewa Zemann, Austria
001
  Stand der aktuellen Forschung in der psychia- 
trischen Pflege: international und national
Ewa Zemann, Austria
002
  Vorstellung des Studienganges Master  
Psychiatrische Pflege SFU mit besonderer Hervorhe-
bung des Forschungsansatzes
Thomas Stephenson, Austria
Johann Steinberger
003
  Evidenzbasierte Leitlinien in der psychiatri-
schen Pflege: ein Vergleich D / A / CH – Kanada
Gerhard Schoßmaier, Austria
004
  Präsentation der Literaturrecherche „Angehö-
rige als sekundäre Patientengruppe?” mit beson-
derem Blick auf die vorhandenen Quellen aus der 
Forschung der psychiatrischen Pflege
Katharina Scharer, Austria
S-104 (d) 
Symposium (German)
10:00 – 11:30
 | 
Room Weimar 3
TOPIC 31:
 Suicide and psychiatric emergencies
 
Suizidprävention – ein psychiatrisch-psychothe-
rapeutischer Auftrag
›
 DGPPN Section: Suizidologie
Chairs: 
Manfred Wolfersdorf, Germany 
Barbara Schneider, Germany
001
  Suizidprävention in der tiefenpsychologisch- 
psychoanalytischen Behandlung
Elmar Etzersdorfer, Germany
002
  Suizidprävention und Verhaltenstherapie
Barbara Schneider, Germany
003
  Suizidprävention und Psychopharmakotherapie
Thomas Bronisch, Germany
004
  Suizidprävention im psychiatrischen Kranken-
haus
Manfred Wolfersdorf, Germany
S-105 (d) 
Symposium (German)
10:00 – 11:30
 | 
Room Weimar 5
TOPIC 32:
 Violence and trauma
 
Neue Versorgungsaspekte in der Psycho- 
traumatologie
›
 DeGPT – Deutschsprachige Gesellschaft für Psycho- 
traumatologie
Chairs: 
Astrid Lampe, Austria 
Lutz Goldbeck, Germany
001
  Evaluation eines zertifizierten Traumafortbil-
dungs-Curriculums durch Absolventen
Lutz Goldbeck, Germany
002
  Aktueller Stand der S3-Leitlinie PTSD: Konse-
quenzen und Implikationen für die Praxis
Ingo Schäfer, Germany
003
  Psychotherapeutische Versorgung von Flücht-
lingen – Herausforderungen und Perspektiven
Birgit Wagner, Germany
S-106 (d) 
Symposium (German)
10:00 – 11:30
 | 
Room M6
TOPIC 18:
 Pharmacotherapy
 
Genesung von Psychosen und Neuroleptika – die 
Praxis der Reduktion aus trialogischer Perspektive
Chairs: 
Jann Schlimme, Germany 
Thelke Scholz, Germany
001
  Der Stellenwert der Neuroleptika im individuel-
len Genesungsprozess von Psychosen
Jann Schlimme, Germany
002
  Neuroleptika-Reduktion: Wie ging das?
Thelke Scholz, Germany
003
  Begleitung der Neuroleptika-Reduktion – die 
Angehörigenperspektive
Renate Seroka, Germany
004
  Begleitung der Antidepressiva – Neuroleptika- 
Reduktion – die Facharztperspektive
Uwe Gonther, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
231
WS-27 Workshop
10:00 – 11:30
 | 
Room R12
TOPIC 3:
 Psychotic disorders
Appropriate antipsychotic treatment selection in 
early phase psychosis
Chair: 
Phil Tibbo, Canada
Speaker: 
Marc-Andre Roy, Canada
OS-61 
Oral Presentation Session
10:00 – 11:30
 | 
Room R4
TOPIC 1:
 Neurocognitive disorders, organic mental 
disorders, dementia
Alzheimer's disease: diagnosis and assessment
Chairs: 
Carlos Augusto de Mendonça Lima, Switzerland 
Frank Jessen, Germany
001
  Value of amyloid imaging for differential diag-
nosis of dementia
Sabine Hellwig, Germany
Lars Frings, Tobias Bormann, Timo Spehl, Stefan Klöppel, 
Werner Vach, Ralph Buchert, Philipp T. Meyer
002
  Pupillometric assessment of cholinergic func-
tioning in subjects of Alzheimer's disease: a study 
from India
Abdul Qadir Jilani, India
Shrikant Srivastava
003
  Validation of the regression-based newly 
normed SKT for the detection of MCI, depression 
and dementia
Mark Stemmler, Germany
Hartmut Lehfeld
004
  Limited accuracy for the detection of subjective 
cognitive decline and prodromal Alzheimer's disease 
based on multicenter resting-state functional con-
nectivity – results from the DZNE DELCODE study
Martin Dyrba, Germany
Coraline Metzger, Michel Grothe, Frank Jessen, Emrah 
Düzel, Annika Spottke, Peter Nestor, Katharina Buerger, 
Anja Schneider, Oliver Peters, Josef Priller, Jens Wiltfang, 
Christoph Laske, Stefan Teipel
005
  Concordance between new ELEYSIS® CSF 
assays (Aß(1-42), total tau and phosphorylated tau) 
and amyloid PET Imaging in BioFINDER and ADNI
Manfred Uhr, Germany
Oskar Hansson, Kaj Blennow, John Q. Trojanowski, John 
Seibyl, Erik Stomrud, Tobias Bittner, Christina Rabe, Udo 
Eichenlaub, Leslie M. Shaw
OS-62 
Oral Presentation Session
10:00 – 11:30
 | 
Room R5
TOPIC 3:
 Psychotic disorders
Psychotic disorders: comorbidities
Chairs: 
Stefan Klingberg, Germany 
Wulf Rössler, Switzerland
001
  Effect of insight-oriented internalized stigmati-
zation on drug compliance in patients with schizo-
phrenia and bipolar disorder
Birgül Özkan, Turkey
Gizem Gokalp
002
  The Screen for Cognitive Impairment in Psy-
chiatry (SCIP) in patients with schizophrenia and 
affective disorders: effects of cognitive remediation
Gabriele Sachs, Austria
Eva Maihofer, Hemma Swoboda, Andreas Erfurth
003
  Comparison of neurocognitive domains in 
patients with schizophrenia with and without 
co-morbid obsessive compulsive disorder
Swapnajeet Sahoo, India
004
  A comparative study of the economic burden 
in outpatients with schizophrenia and asthma in a 
Nigerian teaching hospital
Ibidunni Oloniniyi, Nigeria
Adesanmi Akinsulore, Boladale Mapayi
005
  Psychosis in Parkinson's disease: are false sense 
of presence and illusions psychotic symptoms?
Alakananda Dutt, India
Dipanwita Sil, Muktalekha Mukherjee, Chitrita 
Sengupta, Hrishikesh Kumar
006
  Worse performance on selected neuropsycho-
logical tests in abstinent schizophrenic patients with 
a history of cannabis use
Krzysztof Krysta, Poland
OS-63 
Oral Presentation Session
10:00 – 11:30
 | 
Room R6
TOPIC 22:
 Community and social psychiatry
Mental health care, community treatment
Chairs: 
Raoul Borbé, Germany 
Hans Rohlof, The Netherlands
001
  Assertive community treatment – a triological 
network approach in Berlin
Thomas Floeth, Germany
Susanne Ackers
002
  Living museum movement as an innovative 
approach for recovery from severe mental illness
Seong-Su Kim, Republic of Korea

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
232
003
  Community based mental health reform in 
Bosnia and Herzegovina: a 7-year overview
Goran Racetovic, Bosnia and Herzegovina
Slavica Popovic, Brankica Rosic, Slobodanka Grujic 
Timarac
004
  Quality of life of inmates at a destitute home in 
South India: a cross-sectional study
Swati Ravindran, India
Sandeep Patil, Bheemsain Tekkalaki, Sameeran Chate,  
N. M. Patil, Harsha Haridas
OS-64 
Oral Presentation Session
10:00 – 11:30
 | 
Room R7
TOPIC 2:
 Mental disorders due to psychotropic 
substances, behavioural addictions
Substance abuse: risk factors and comorbidities
Chairs: 
Massimo Clerici, Italy 
Falk Kiefer, Germany
001
  Risk factors of substance abuse in bipolar  
disorder: a systematic review and meta-analysis
Sahar Latifi, Germany
Thomas Messer, Gero Lammers, Florian Müller-
Sicheneder, Raluca-Florela Schmidt
002
  Psychiatric symptoms in individuals who chron-
ically use ketamine versus methamphetamine
Yanhui Liao, People's Republic of China
Chang Qi, Qiuxia Wu, Jinsong Tang
003
  How Pavlovian-instrumental transfer contributes 
to our understanding of risk factors for the develop-
ment and maintenance of alcohol use disorders
Maria Garbusow, Germany
Christian Sommer, Stephan Nebe, Miriam Sebold, Sören 
Kuitunen-Paul, Hans-Ulrich Wittchen, Michael Smolka, 
Michael Rapp, Quentin Huys, Florian Schlagenhauf, 
Andreas Heinz
004
  Is epilepsy a ground for severe alcohol with-
drawal?
Pallavi Sinha, India
Amit Garg, Pankaj Kumar, Shailesh Jha
005
  A twin study on prediction of alcohol use disor-
der using all DSM-IV personality disorder criteria
Tom Rosenström, Norway
Fartein Ask Torvik, Ystrom Eivind, Nikolai Olavi 
Czajkowski, Nathan A. Gillespie, Steven H. Aggen, Robert 
F. Krueger, Kenneth S. Kendler, Ted Reichborn-Kjennerud
006
  Prevalence of tobacco use among medical 
students at Ain Shams University, Cairo, Egypt and 
impact of anxiety on smoking among this student 
sample
Heba Tallah Mohamed Wageeh Zaher, Egypt
007
  New psychoactive substances – a challenge for 
psychiatrists in Croatia
Marija Definis-Gojanovic, Croatia
Davorka Sutlovic, Ingrid Prkacin, Zora Jurin
KN-40 
Keynote Lecture
11:45 – 12:15
 | 
Hall A4
 
TOPIC 44:
 Other topics
From Theresienstadt to Buenos Aires – culture and 
memoirs of an Argentinian psychiatrists of Jew-
ish-German roots
Chairs: 
Frank Schneider, Germany 
Helen Herrman, Australia
Speaker: 
Elena Levin, Argentina
KN-42 
Keynote Lecture
11:45 – 12:45
 | 
Hall A3
 
TOPIC 14:
 Neurobiology and genetics
Precision medicine is a fantasy
Chair: 
Andreas Meyer-Lindenberg, Germany
Speaker: 
Stephen Senn, Luxemburg
KN-41 (d) 
Keynote Lecture
11:45 – 13:15
 | 
Hall  A6 / A7
 
TOPIC 44:
 Other topics
 
Irre – wir behandeln die Falschen: unser  
Problem sind die Normalen
Chairs: 
Andreas Küthmann, Germany 
Andreas J. Fallgatter, Germany
Speaker: 
Manfred Lütz, Germany
Preisverleihung:  
DGPPN-Posterpreise
Laudation: 
Andreas Küthmann, Germany
ST-30 (d) 
State-of-the-Art-Symposium
11:45 – 13:15
 | 
Hall A5
 
TOPIC 1:
 Neurocognitive disorders, organic mental 
disorders, dementia
 
Demenzen
Chairs: 
Lutz Frölich, Germany 
Frank Jessen, Germany
Speaker: 
Lutz Frölich, Germany 
Frank Jessen, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
233
ST-31 (d) 
State-of-the-Art-Symposium
11:45 – 13:15
 | 
Hall A2
 
TOPIC 44:
 Other topics
 
Psychische Erkrankung und Schwangerschaft
Chairs: 
Anke Rohde, Germany 
Christof Schaefer, Germany
001
  Peripartales Management zur Rezidivprophylaxe 
bei psychisch kranken Schwangeren
Anke Rohde, Germany
002
  Auswirkungen von Psychopharmaka auf die 
kindliche Entwicklung
Christof Schaefer, Germany
S-379 Symposium
11:45 – 13:15
 | 
Hall A1
 
TOPIC 31:
 Suicide and psychiatric emergencies
Migrants and refugees in CL-psychiatry
Chair: 
Günter Niklewski, Germany
001
  Asylum seekers in the general hospital: data 
from different services
Günter Niklewski, Germany
002
  Migration and suicidality: a person-centered 
and international public mental health perspective
Wolfgang Rutz, Sweden
003
  Suicidality amongst refugees coming to Germany
Meryam Schouler-Ocak, Germany
004
  Cultural brokering in a general hospital – does 
it work?
Quynh Anh Dang, Germany
S-380 Symposium
11:45 – 13:15
 | 
Hall Helsinki 2
 
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
Interdisciplinary concepts and diagnoses of mental 
well-being
›
 WPA Section: Interdisciplinary Collaboration
›
 WPA Section: Psychiatry, Medicine & Primary Care
›
 WPA Section: Psychoneuroendocrinology
Chairs: 
Uriel Halbreich, USA 
David Baron, USA
001
  Comprehensive well-being: diagnostic implica-
tions and symptoms
Uriel Halbreich, USA
002
  Intra-cellular dysregulations across DSM diagnosis
Ghanshyam Pandey, USA
Uriel Halbreich
003
  Mood and behavioral symptoms in general 
medicine and primary care
David Baron, USA
S-381 Symposium
11:45 – 13:15
 | 
Hall Paris 1
 
TOPIC 24:
 Forensic psychiatry and assessment
Compulsory treatment and the use of physical re-
straints in Southern Europe
›
 ZONE 8: Southern Europe
Chairs: 
Zvi Zemishlany, Israel 
Fatih Oncu, Turkey
001
  Compulsory treatment and the use of physical 
restraints in Israel
Zvi Zemishlany, Israel
002
  Compulsory treatment and the use of physical 
restraints in Italy – the proposed national protocol 
for mandatory psychiatric treatment
Enrico Zanalda, Italy
003
  Compulsory treatment and the use of physical 
restraints in Turkey
Can Ger, Turkey
S-382 Symposium
11:45 – 13:15
 | 
Hall Paris 2
 
TOPIC 17:
 Psychotherapy
Integration of psychoanalysis in psychiatric treatment
›
 WPA Section: Psychoanalysis in Psychiatry
Chairs: 
Maria Ammon, Germany 
Michel Botbol, France
001
  The relevance of analytic group-dynamic for 
psychoanalysis in psychiatry
Ilse Burbiel, Germany
002
  Psychoanalysis as the primary basis of treat-
ment in the only clinic of psychiatry in Arabic North 
Africa
Hachem Tyal, Morocco
003
  Dynamic psychiatry an integrative theoretical 
and practical multidisciplinary treatment concept
Maria Ammon, Germany
004
  The internal path
Hervé Granier, France

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
234
S-383 Symposium
11:45 – 13:15
 | 
Hall New York 1
 
TOPIC 38:
 Human Rights
Human rights and substitute decision-making  
versus supported decision-making
Chairs: 
Andreas Heinz, Germany 
Sabine Müller, Germany
001
  New models of community care
Norman Sartorius, Switzerland
002
  Substitute and supported decision-making in 
the perspective of a family member
Gudrun Schliebener, Germany
003
  Medical treatment as benefit or violation of 
human rights – a challenge for psychiatry
Margret Osterfeld, Germany
004
  Decision-making capacity and supported 
decision-making – the position of the Central Ethics 
Committee of the German Medical Association
Sabine Müller, Germany
S-384 Symposium
11:45 – 13:15
 | 
Hall New York 3
 
TOPIC 22:
 Community and social psychiatry
Open dialogue in Europe – state-of-the-art and new 
developments
›
 DGPPN Section: Psychosocial Care Research
Chairs: 
Sebastian von Peter, Germany 
Thomas Becker, Germany
001
  Trends of implementation and training practic-
es within and outside the mental health trusts in the 
UK with special emphasis on support and inclusion 
of peer experts
Nick Putnam, United Kingdom
002
  Multicenter implementation of open dialogue 
in Italy with pilot study to evaluate capacity of 
MHDs to work with open dialogue
Guiseppe Salamina, Italy
003
  Implementation by seduction – 10 years of 
open dialogue training in Germany and some other 
countries
Volkmar Aderhold, Germany
004
  The open dialogue approach in Western  
Lapland over 30 years of practise and research
Jyri J. Taskila, Finland
S-385 Symposium
11:45 – 13:15
 | 
Hall London 3
 
TOPIC 20:
 Prevention and health promotion
Prediction and prevention of psychoses – what has 
been achieved and where to go next?
›
 DGPPN Section: Prediction in Psychiatry
›
 DGPPN Section: Prevention of Mental Disorders
Chairs: 
Joachim Klosterkötter, Germany 
Patrick McGorry, Australia
001
  Prediction of psychoses – state-of-the-art and 
future perspectives
Frauke Schultze-Lutter, Switzerland
002
  Optimization and personalization of psychoses 
prediction by means of biomarkers
Nikolaos Koutsouleris, Germany
003
  Indicated prevention of psychoses – state-of-
the-art and future perspectives
Patrick McGorry, Australia
004
  Latest developments and implementation 
possibilities of psychological psychosis prevention 
strategies
Mark van der Gaag, The Netherlands
Helga Ising
S-386 Symposium
11:45 – 13:15
 | 
Hall London 2
 
TOPIC 32:
 Violence and trauma
Mental health care in areas ridden by political 
repression and armed conflict
Chairs: 
Christian Pross, Germany 
Mechthild Wenk-Ansohn, Germany
001
  Mental health services and psychosocial sup-
port for Syrian refugees in Lebanon – provision of 
assistance in emergency context
Suzanne Jabbour, Lebanon
002
  Does effective medical documentation help 
trauma survivors' healing processes through recog-
nition and justice?
Sebnem Korur Fincanci, Turkey
003
  Effects of ill-treatment in Georgian prisons – 
morbidity and challenges for mental health care
Lela Tsiskarishvili, Republic of Georgia
004
  How to cope with the aftermath of suicide 
bombings: establishing a psychosocial solidarity 
network in Turkey
Sahika Yüksel, Turkey

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
235
S-387 Symposium
11:45 – 13:15
 | 
Room  M2 / M3
TOPIC 2:
 Mental disorders due to psychotropic 
substances, behavioural addictions
Dual disorders across the lifespan
›
 WPA Section: Dual Disorders / Pathology
Chairs: 
Jose Martinez-Raga, Spain 
Yatan Pal Singh Balhara, India
001
  Internet addiction and occurring psychiatric 
disorders among emerging adults
Yatan Pal Singh Balhara, India
002
  Dual depression: where are we?
Marta Torrens, Spain
003
  Improving treatment for individuals with